 Traitement en cours... |
Traitement en cours... |
 |
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
April 22-25, 2013 | Chicago, IL | BIO International Convention 
The annual Bio International Convention, will take place on 22nd -25th April at the McCormick Place, Chicago USA.Throughout the event, XenTech’s COO, Pascal Leuraud will be available to meet with attendees. April 6-10, 2013 | Washington, DC | Annual AACR meeting 
This meeting brings together the best and latest findings in all major areas of cancer research. Jean-Gabriel Judde, Stefano Cairo and Paola Bazzacco will be attending this major event in oncology. Meet them at the Booth #515 and visit our poster! Poster Title: Liver cancer patient-derived xenografts to improve disease management in childhood and adolescence: perspectives and challenges of personalized medicine. Session ID: Tumor Biology 33 Session Date and Time: Tuesday Apr 9, 2013 8:00 AM - 12:00 PM Location: Hall A-C, Poster Section 19 March 14-15, 2013 | Bologna, Italy | SIOPEL group Spring Meeting  Stefano Cairo, Head of molecular biology department at XenTech, will be attending the SIOPEL group Spring Meeting. The ultimate goal of the SIOPEL study group is to improve the prognosis and the quality of life of children affected by primary childhood liver tumors. Primary hepatic tumours represent less than 1% of all childhood malignancies. Their frequency according to the different series is of about 0.8 - 1 case per million children less than 15 years of age per year. Hepatoblastoma (HB) is by far the most common histological subtype of primary malignant hepatic tumors occurring in children less than 15 years of age, followed by hepatocellular carcinoma (HCC). Please contact us to meet Stefano Cairo and discuss how PDX may foster the development of new therapies for rare cancers such as hepatoblastoma... March 7-9, 2013 | Barcelona, Spain | 1st International Congress on Controversies in Personnalized Oncology  The International Congress on Controversies in Personalized Oncology (CONPO) is intended as an exclusive forum for international experts to share and compare experiences, in order to outline the potentially best treatments for patients within breast, lung, colon and melanoma cancer areas. Contact us and meet us at the booth #2! February 13-15, 2013 | Lyon, France | 1st international symposium of the Cancer Research Center of Lyon (CRCL) 
This symposium will bring together scientists and clinicians interested in the latest advances across the major sectors of cancer research. Through the participation of internationally known scientists, the symposium will address crucial questions, both in terms of scientific knowledge and clinical applications. Five sessions will be organized:
Contact us to meet our scientists! December 4-8, 2012 | San Antonio | San Antonio Breast Cancer Symposium 
This symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. Meet Jean-Gabriel Judde, Stefano Cairo and Sabrina Serpillon at the Booth # 421! November 6-9, 2012 | Dublin | 24th EORTC-NCI-AACR Symposium on MOLECULAR TARGETS AND MOLECULAR THERAPEUTICS Meet Paola Bazzacco, Myriam Lassalle and Olivier Deas at our Booth (# B14)! October 2-3, 2012 | Boston - 10th Annual Functional Genomics Screening Strategies  Stefano Cairo, Head of R&D laboratory at XenTech, will be attending the 10th Annual Functional Genomics Screening Strategies. This conference will cover the latest in the use of chemical genomics tools, cDNA overexpression assays and the potential use of micro RNA (miRNA) and long non-coding RNAs for identifying and validating drug targets, exploring unknown cellular pathways, and for performing translational studies such as, biomarker discovery, drug modifier screens and more. More info... Please contact us to meet Stefano Cairo and discuss how functional genomic screening strategies can be developed in PDX models! 26-28 September 2012 - Amsterdam, The Netherlands - Symposium on Preclinical Assays in Cancer Therapy Marie-france Poupon and Paola Bazzacco are attending the Symposium on Preclinical Assays in Cancer Therapy. This symposium will provide an overview of preclinical approaches aimed at understanding basic mechanisms of therapy response and resistance in order to improve personalized cancer therapy. More info... Location: The Netherlands Cancer Institute (Piet Borst Auditorium), Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands June 15, 2012 - Paris, France - 1st European Symposium of Biopathology 
Jean-Gabriel JUDDE, CSO at XenTech, is giving a lecture entitled: "Tumor xenografts preclinical models: contribution to the development of personalized therapies". Location: MAUDITORIUM PARIS CENTRE MARCEAU - 12 avenue Marceau 75008 Paris Tuesday, June 5, 2012, 4:00 PM – 5:00 PM. More info... June 5, 2012 - Portland, OR, USA - Knight Cancer Institute Seminar Series Stefano Cairo, Head of R&D laboratory at XenTech, is giving a lecture entitled: "HEPATOBLASTOMA: TRANSLATING MOLECULAR APPROACHES AND PRECLINICAL MODELS INTO IMPROVED PATIENT STRATIFICATION AND TREATMENT EFFICACY". Campus Location: Marquam Hill - OHSU Main Hospitail 8B60 Auditorium (8th Floor) 3181 SW Sam Jackson Park Rd Portland, OR 97239. Friday June 15, 2012, 3:40 PM. More info |
|
||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||
| Design by Ineiaki | Sitemap | Terms of use | |||||||||||||||||||||||||||||
